Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-046906

Chief Accounting Officer sold 953 shares at an average $0.75 ($715)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-19 Sale : show line 1 in the form −473 $0.75 $355 78,099 D
2024-04-22 Sale : show line 2 in the form −480 $0.75 $360 77,619 D
Open-market sales · 953 sh · avg $0.75 · $715
Loading xslF345X05/ownership.xml…